BI
Bioelectronics Corporation
BIEL · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $7.41M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 14.94x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 32.45%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 187.62%
Op. margin 79.17%
FCF margin 33.09%
Quality
79 /100
Excellent ROA 2,148.02%
Asset turnover 11.45x
ROIC 20.93%
Debt
0 /100
High Int. coverage -0.73x
Current ratio 0.01x
Net debt/EBITDA N/A
Stability
15 /100
Unstable Rev. volatility 28.59%
Profitable years 0
Beta 2.05x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIEL
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Kelly A. Whelan
Employees
9
Headquarters
Frederick